Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00188) | |||||
---|---|---|---|---|---|
Name |
Dexmethylphenidate
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Dexmethylphenidate; d-threo-Methylphenidate; (+)-threo-Methylphenidate; Focalin; 40431-64-9; UNII-M32RH9MFGP; d-Methylphenidate; Dexmethylphenidate [INN]; M32RH9MFGP; CHEMBL827; methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate; CHEBI:51860; methyl (R)-phenyl[(R)-piperidin-2-yl]acetate; Focalin XR; Dexmethylphenidate (INN); methyl (2R)-phenyl[(2R)-piperidin-2-yl]acetate; Methyl D-phenidate; Dex methylphenidate; threo-(+)-Methylphenidate; Attenade; dexmetilfenidato; dexmethylphenidatum; dex-methylphenidate; d-threo methylphenidate; Methylphenidate d-threo-form; SCHEMBL34326; GTPL7554; DTXSID70893769; ZINC896711; 2-Piperidineacetic acid, alpha-phenyl-, methyl ester, (alphaR,2R)-; BDBM50062915; PDSP1_000871; PDSP1_000903; PDSP2_000857; PDSP2_000889; DB06701; D07806; Q1207210; UNII-207ZZ9QZ49 component DUGOZIWVEXMGBE-CHWSQXEVSA-N; 2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester, (.alpha.S,2S)-; 40572-71-2
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Attention deficit hyperactivity disorder | ICD-11: 6A05 | [1] | ||
PubChem CID | |||||
Formula |
C14H19NO2
|
||||
Canonical SMILES |
COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2
|
||||
InChI |
1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1
|
||||
InChIKey |
DUGOZIWVEXMGBE-CHWSQXEVSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=154101"></iframe>
|
![]() |
|||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 233.31 | Topological Polar Surface Area | 38.3 | |
XlogP | 0.2 | Complexity | 249 | ||
Heavy Atom Count | 17 | Rotatable Bond Count | 4 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Dexmethylphenidate 10 mg capsule | Click to Show/Hide the Full List of Formulation(s): 9 Formulation(s) | |||||
Drug Formulation 1 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 6000; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose 2208 (3 mpa.s); Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [4] | |||
Drug Formulation 2 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Isopropyl alcohol; Ferrosoferric oxide; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 400; 1-propoxy-2-propanol; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 3 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 4 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 5 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 1; Amaranth; Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Ethylcellulose, unspecified; Gelatin, unspecified; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromellose, unspecified; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 6 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 1; Amaranth; Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Ethylcelluloses; Gelatin; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromelloses; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 7 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Novartis Pharmaceuticals Corporation | |||||
Drug Formulation 8 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Physicians Total Care | |||||
Drug Formulation 9 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Dextrose, unspecified form; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:1); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Sandoz | |||||
Dexmethylphenidate 15 mg capsule | Click to Show/Hide the Full List of Formulation(s): 11 Formulation(s) | |||||
Drug Formulation 1 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 6000; Ammonio methacrylate copolymer type b; Fd&c green no. 3; Gelatin, unspecified; Hypromellose 2208 (3 mpa.s); Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [4] | |||
Drug Formulation 2 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Isopropyl alcohol; Ferrosoferric oxide; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 400; 1-propoxy-2-propanol; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 3 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c red no. 28; Fd&c blue no. 1; Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Ethylcellulose, unspecified; Gelatin, unspecified; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromellose, unspecified; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
D&C red no. 28 | DIG Info | Organic anion transporter 1 (Ki = 0.064 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 4 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c red no. 28; Fd&c blue no. 1; Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Ethylcelluloses; Gelatin; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromelloses; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
D&C red no. 28 | DIG Info | Organic anion transporter 1 (Ki = 0.064 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 5 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Fd&c yellow no. 6; Sucrose; Talc; Titanium dioxide; Triacetin; Triethyl citrate; Silicon dioxide; Gelatin; Hypromelloses; Methacrylic acid; Polydextrose; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 6 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Ammonia; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 7 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Ammonia; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 8 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Dextrose; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:1); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | American Health Packaging | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Drug Formulation 9 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Dextrose, unspecified form; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:1); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Drug Formulation 10 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Physicians Total Care; Stat Rx USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Drug Formulation 11 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Novartis Pharmaceuticals Corporation | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Dexmethylphenidate 20 mg capsule | Click to Show/Hide the Full List of Formulation(s): 9 Formulation(s) | |||||
Drug Formulation 1 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 6000; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose 2208 (3 mpa.s); Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [4] | |||
Drug Formulation 2 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Isopropyl alcohol; Ferrosoferric oxide; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 400; 1-propoxy-2-propanol; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 3 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c red no. 28; D&c red no. 33; Fd&c blue no. 1; Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Ethylcellulose, unspecified; Gelatin, unspecified; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromellose, unspecified; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
D&C red no. 33 | DIG Info | Solute carrier SLCO2B1 (Ki = 58.1 uM) | [3] | |||
D&C red no. 28 | DIG Info | Organic anion transporter 1 (Ki = 0.064 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 4 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c red no. 28; D&c red no. 33; Fd&c blue no. 1; Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Ethylcelluloses; Gelatin; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromelloses; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
D&C red no. 33 | DIG Info | Solute carrier SLCO2B1 (Ki = 58.1 uM) | [3] | |||
D&C red no. 28 | DIG Info | Organic anion transporter 1 (Ki = 0.064 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 5 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Ammonia; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 6 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Dextrose; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:1); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Avera McKennan Hospital | |||||
Drug Formulation 7 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Dextrose, unspecified form; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:1); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Sandoz | |||||
Drug Formulation 8 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Physicians Total Care | |||||
Drug Formulation 9 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Novartis Pharmaceuticals Corporation | |||||
Dexmethylphenidate 25 mg capsule | Click to Show/Hide the Full List of Formulation(s): 5 Formulation(s) | |||||
Drug Formulation 1 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 6000; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose 2208 (3 mpa.s); Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [4] | |||
Drug Formulation 2 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Isopropyl alcohol; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 400; 1-propoxy-2-propanol; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 3 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Dextrose, unspecified form; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:1); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Drug Formulation 4 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Novartis Pharmaceuticals Corporation | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Drug Formulation 5 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Ethylcelluloses; Gelatin; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromelloses; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Dexmethylphenidate 30 mg capsule | Click to Show/Hide the Full List of Formulation(s): 11 Formulation(s) | |||||
Drug Formulation 1 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 6000; Aluminum oxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromellose 2208 (3 mpa.s); Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [4] | |||
Drug Formulation 2 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 6000; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose 2208 (3 mpa.s); Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [4] | |||
Drug Formulation 3 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 4 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 5 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Isopropyl alcohol; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 400; 1-propoxy-2-propanol; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 6 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Fd&c yellow no. 6; Sucrose; Talc; Titanium dioxide; Triacetin; Triethyl citrate; Silicon dioxide; Gelatin, unspecified; Hypromellose, unspecified; Methacrylic acid - methyl methacrylate copolymer (1:1); Methacrylic acid - methyl methacrylate copolymer (1:2); Polydextrose; Polyethylene glycol, unspecified
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | American Health Packaging | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 7 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Fd&c yellow no. 6; Sucrose; Talc; Titanium dioxide; Triacetin; Triethyl citrate; Silicon dioxide; Gelatin; Hypromelloses; Methacrylic acid; Polydextrose; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 8 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Ethylcellulose, unspecified; Gelatin, unspecified; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromellose, unspecified; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 9 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Ethylcelluloses; Gelatin; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromelloses; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 10 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Novartis Pharmaceuticals Corporation | |||||
Drug Formulation 11 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Dextrose, unspecified form; Methacrylic acid - methyl methacrylate copolymer (1:1); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Sandoz | |||||
Dexmethylphenidate 35 mg capsule | Click to Show/Hide the Full List of Formulation(s): 5 Formulation(s) | |||||
Drug Formulation 1 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 6000; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose 2208 (3 mpa.s); Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [4] | |||
Drug Formulation 2 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Isopropyl alcohol; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 400; 1-propoxy-2-propanol; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 3 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 1; Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Ethylcelluloses; Gelatin; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromelloses; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 4 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Dextrose, unspecified form; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:1); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Drug Formulation 5 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Novartis Pharmaceuticals Corporation | |||||
Dexmethylphenidate 40 mg capsule | Click to Show/Hide the Full List of Formulation(s): 6 Formulation(s) | |||||
Drug Formulation 1 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 6000; Aluminum oxide; Ammonio methacrylate copolymer type b; Fd&c green no. 3; Gelatin; Hypromellose 2208 (3 mpa.s); Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [4] | |||
Drug Formulation 2 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 6000; Ammonio methacrylate copolymer type b; Fd&c green no. 3; Gelatin, unspecified; Hypromellose 2208 (3 mpa.s); Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [4] | |||
Drug Formulation 3 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Isopropyl alcohol; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Triethyl citrate; Water; Polyethylene glycol 4000; 1-propoxy-2-propanol; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [5] | |||
Polyethylene glycol 4000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 40 %) | [4] | |||
Drug Formulation 4 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Ammonia; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 5 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Dextrose, unspecified form; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:1); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Drug Formulation 6 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Novartis Pharmaceuticals Corporation | |||||
Dexmethylphenidate 5 mg capsule | Click to Show/Hide the Full List of Formulation(s): 11 Formulation(s) | |||||
Drug Formulation 1 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 6000; Aluminum oxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromellose 2208 (3 mpa.s); Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Avera McKennan Hospital | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [4] | |||
Drug Formulation 2 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Ferrosoferric oxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Polyethylene glycol 6000; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose 2208 (3 mpa.s); Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [4] | |||
Drug Formulation 3 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Isopropyl alcohol; Ferrosoferric oxide; Talc; Titanium dioxide; Triethyl citrate; Fd&c red no. 3; Polyethylene glycol 400; 1-propoxy-2-propanol; Gelatin; Methacrylic acid - ethyl acrylate copolymer (1:1) type a; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Par Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [5] | |||
FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [2] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [4] | |||
Drug Formulation 4 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Fd&c blue no. 2; Ammonia; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Silicon dioxide; Ammonio methacrylate copolymer type b; Dimethicone; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 5 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 1; Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Ethylcellulose, unspecified; Gelatin, unspecified; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromellose, unspecified; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [2] | |||
Drug Formulation 6 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 1; Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Ethylcelluloses; Gelatin; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromelloses; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [2] | |||
Drug Formulation 7 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 1; Acetyltributyl citrate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Ethylcelluloses; Gelatin; Hypromellose acetate succinate 06081224 (3 mm2/s); Hypromelloses; Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [2] | |||
Drug Formulation 8 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Fd&c blue no. 2; Ammonia; Propylene glycol; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Methacrylic acid - methyl methacrylate copolymer (1:1); Shellac; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 9 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Talc; Titanium dioxide; Triethyl citrate; Ammonio methacrylate copolymer type a; Dextrose, unspecified form; Gelatin; Methacrylic acid - methyl methacrylate copolymer (1:1); Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Drug Formulation 10 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Novartis Pharmaceuticals Corporation | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Drug Formulation 11 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide yellow; Talc; Titanium dioxide; Triethyl citrate; Dextrose; Gelatin; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Physicians Total Care | |||||
Dexmethylphenidate 5 mg tablet | Click to Show/Hide the Full List of Formulation(s): 9 Formulation(s) | |||||
Drug Formulation 1 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Avera McKennan Hospital | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 2 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Silicon dioxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 3 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | GAVIS Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [7] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 4 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Talc; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Avera McKennan Hospital; Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 5 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; D&c yellow no. 10; Magnesium stearate; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | KVK Tech | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 6 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Novartis Pharmaceuticals Corporation | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 7 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 8 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Aluminum oxide; Microcrystalline cellulose; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rhodes Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 9 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Cellulose, microcrystalline; Magnesium; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Tris Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Dexmethylphenidate 2.5 mg tablet | Click to Show/Hide the Full List of Formulation(s): 8 Formulation(s) | |||||
Drug Formulation 1 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | GAVIS Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [7] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 2 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Lactose monohydrate; Fd&c blue no. 2; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 3 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Talc; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 4 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Fd&c blue no. 1; Magnesium stearate; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | KVK Tech | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 5 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Novartis Pharmaceuticals Corporation | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 6 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 7 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Aluminum oxide; Microcrystalline cellulose; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rhodes Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 8 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c blue no. 1; Cellulose, microcrystalline; Magnesium; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Tris Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Dexmethylphenidate 10 mg tablet | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Lactose monohydrate; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | GAVIS Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [7] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 2 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Silicon dioxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 3 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Talc; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 4 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | KVK Tech | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 5 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Novartis Pharmaceuticals Corporation; Sandoz | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 6 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Microcrystalline cellulose; Sodium starch glycolate type a potato; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rhodes Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 7 |
DFM Info
![]() |
|||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Cellulose, microcrystalline; Magnesium; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Tris Pharma | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.